Frequently Asked Questions
The market is segmented based on Segmentation, By Mechanism (Retractable, Non-Retractable, Others), Clinical Indication (Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others) - Industry Trends and Forecast to 2031.
.
The Global Auto Disable Syringes Market size was valued at USD 23.50 USD Billion in 2023.
The Global Auto Disable Syringes Market is projected to grow at a CAGR of 11.87% during the forecast period of 2024 to 2031.
The major players operating in the market include BD, Iscon Surgicals , AlShifa Medical Products Co., Hindustan Syringes & Medical Devices Ltd, Retractable Technologies , Smiths Group plc, Baxter, B. Braun Melsungen AG, Terumo Corporation, Medtronic, Hamilton Company, PharmaJet, VOGT MEDICAL, SANAVITA PHARMACEUTICALS GMBH, JMI Group, AdvaCare Pharma., ZIBO EASTMED HEALTHCARE PRODUCTS CO. , SWARG PHARMA, Nipro Medical Corporation, Boston Scientific Corporation-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
